PUBLISHER: 360iResearch | PRODUCT CODE: 1591897
PUBLISHER: 360iResearch | PRODUCT CODE: 1591897
Human Reproductive Technologies Market by Type (Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination), Application (Fertility Preservation, Genetic Screening, Infertility Treatment), End-User - Global Forecast 2025-2030
The Human Reproductive Technologies Market was valued at USD 29.84 billion in 2023, expected to reach USD 31.82 billion in 2024, and is projected to grow at a CAGR of 6.66%, to USD 46.89 billion by 2030.
Human Reproductive Technologies are a diverse set of treatments and technologies aimed at assisting human reproduction through medical and scientific interventions. This scope includes in vitro fertilization (IVF), artificial insemination, fertility drugs, surrogacy, and emerging genomics technologies. The necessity for these technologies is primarily driven by the increasing prevalence of infertility due to delayed childbearing, lifestyle factors, and certain medical conditions. Application-wise, they are extensively utilized in fertility clinics, hospitals, and healthcare research institutions. End-use spans across individual couples desiring children, same-sex couples, and single parents seeking reproductive assistance.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 29.84 billion |
| Estimated Year [2024] | USD 31.82 billion |
| Forecast Year [2030] | USD 46.89 billion |
| CAGR (%) | 6.66% |
The market is significantly influenced by the growing awareness and acceptance of reproductive health technologies, advancements in medical sciences, and supportive government regulations for fertility tourism. Moreover, rising disposable income and better healthcare infrastructure in emerging economies drive demand. However, the market faces limitations such as high costs of treatment, ethical and legal concerns, and the potential for psychological stress among patients. Challenges include societal stigmas and varied legal frameworks across different regions impacting technology adoption.
Potential growth opportunities lie in developing affordable and accessible treatment options, personalized medicine adapting reproductive technologies to individual genetic profiles, and advancing technologies such as artificial intelligence to predict treatment outcomes effectively. For businesses looking to capitalize on these opportunities, investment in research and development to create innovative fertility solutions, forming partnerships with healthcare providers for wider service distribution, and advocating for policies that support accessibility and insurance coverage can be strategic steps. Innovation hotspots include non-invasive fertility diagnostics, embryo and gamete cryopreservation, and mobile health applications for patient engagement and education. The market is characterized by rapid technological advancements, increasing competition, and potential collaboration between biotechnology firms, pharmaceuticals, and healthcare sectors to address unmet needs effectively while navigating ethical and regulatory landscapes.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Reproductive Technologies Market
The Human Reproductive Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Changing lifestyles and rising prevalence of infertility and fertility-related disorders
- Growing medical tourism for specialized fertility treatments
- Increasing awareness and acceptance of fertility treatments
- Market Restraints
- High cost and limited insurance coverage for fertility treatments
- Market Opportunities
- Advancements and innovations in human reproductive technology for more effective treatment
- Patents and copyrights for innovations in the reproductive technologies
- Market Challenges
- Limited success rates and associated health risks
Porter's Five Forces: A Strategic Tool for Navigating the Human Reproductive Technologies Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Reproductive Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Human Reproductive Technologies Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Reproductive Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Human Reproductive Technologies Market
A detailed market share analysis in the Human Reproductive Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Reproductive Technologies Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Reproductive Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Human Reproductive Technologies Market
A strategic analysis of the Human Reproductive Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Human Reproductive Technologies Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Aurobindo Pharma, Bayer AG, CooperSurgical Fertility Solutions, Eli Lilly and Company, European Sperm Bank, Evofem Biosciences, Inc., Ferring B.V., GSK PLC, InSEM Fertility Solutions, INVO Bioscience, KG Medical Industries, Mankind Pharma, Merck KGaA, Microm UK Ltd., Monash IVF Group, Pfizer Inc., Pride Angel, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., V Conceive, Vitrolab AB, and Voxtur Bio Ltd..
Market Segmentation & Coverage
This research report categorizes the Human Reproductive Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Assisted Reproductive Technology, In Vitro Fertilizartion, Intrauterine Insemination, Preimplantation Genetic Testing, and Surrogacy.
- Based on Application, market is studied across Fertility Preservation, Genetic Screening, and Infertility Treatment.
- Based on End-User, market is studied across Fertility Clinics, Hospitals, and Research & Academic Institutes.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Changing lifestyles and rising prevalence of infertility and fertility-related disorders
- 5.1.1.2. Growing medical tourism for specialized fertility treatments
- 5.1.1.3. Increasing awareness and acceptance of fertility treatments
- 5.1.2. Restraints
- 5.1.2.1. High cost and limited insurance coverage for fertility treatments
- 5.1.3. Opportunities
- 5.1.3.1. Advancements and innovations in human reproductive technology for more effective treatment
- 5.1.3.2. Patents and copyrights for innovations in the reproductive technologies
- 5.1.4. Challenges
- 5.1.4.1. Limited success rates and associated health risks
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Human Reproductive Technologies Market, by Type
- 6.1. Introduction
- 6.2. Assisted Reproductive Technology
- 6.3. In Vitro Fertilizartion
- 6.4. Intrauterine Insemination
- 6.5. Preimplantation Genetic Testing
- 6.6. Surrogacy
7. Human Reproductive Technologies Market, by Application
- 7.1. Introduction
- 7.2. Fertility Preservation
- 7.3. Genetic Screening
- 7.4. Infertility Treatment
8. Human Reproductive Technologies Market, by End-User
- 8.1. Introduction
- 8.2. Fertility Clinics
- 8.3. Hospitals
- 8.4. Research & Academic Institutes
9. Americas Human Reproductive Technologies Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Human Reproductive Technologies Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Human Reproductive Technologies Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. AbbVie Inc.
- 3. Aurobindo Pharma
- 4. Bayer AG
- 5. CooperSurgical Fertility Solutions
- 6. Eli Lilly and Company
- 7. European Sperm Bank
- 8. Evofem Biosciences, Inc.
- 9. Ferring B.V.
- 10. GSK PLC
- 11. InSEM Fertility Solutions
- 12. INVO Bioscience
- 13. KG Medical Industries
- 14. Mankind Pharma
- 15. Merck KGaA
- 16. Microm UK Ltd.
- 17. Monash IVF Group
- 18. Pfizer Inc.
- 19. Pride Angel
- 20. Sandoz International GmbH
- 21. Sun Pharmaceutical Industries Ltd.
- 22. Teva Pharmaceutical Industries Ltd.
- 23. V Conceive
- 24. Vitrolab AB
- 25. Voxtur Bio Ltd.
LIST OF FIGURES
- FIGURE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET RESEARCH PROCESS
- FIGURE 2. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET DYNAMICS
- TABLE 7. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY ASSISTED REPRODUCTIVE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY IN VITRO FERTILIZARTION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY PREIMPLANTATION GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY SURROGACY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY GENETIC SCREENING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY INFERTILITY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 23. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 24. AMERICAS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 25. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 26. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 27. ARGENTINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 28. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 30. BRAZIL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 31. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 32. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 33. CANADA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 34. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 35. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 36. MEXICO HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 39. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 40. UNITED STATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 43. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 44. ASIA-PACIFIC HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 45. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 46. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 47. AUSTRALIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 48. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 49. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 50. CHINA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 51. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 52. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 53. INDIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 54. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 56. INDONESIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 57. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 58. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 59. JAPAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 60. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 62. MALAYSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 63. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 64. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 65. PHILIPPINES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 66. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 68. SINGAPORE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 69. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 70. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 71. SOUTH KOREA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 72. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 74. TAIWAN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 75. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 76. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 77. THAILAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 78. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 80. VIETNAM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 85. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 86. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 87. DENMARK HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 88. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 90. EGYPT HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 91. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 92. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 93. FINLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 94. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 96. FRANCE HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 97. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 98. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 99. GERMANY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 100. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 101. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 102. ISRAEL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 103. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 104. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 105. ITALY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 106. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 107. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 108. NETHERLANDS HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 109. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 110. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 111. NIGERIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 112. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 113. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 114. NORWAY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 115. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 116. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 117. POLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 118. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 119. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 120. QATAR HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 121. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 122. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 123. RUSSIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 124. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 125. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 126. SAUDI ARABIA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 127. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 128. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 129. SOUTH AFRICA HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 130. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 131. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 132. SPAIN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 133. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 134. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 135. SWEDEN HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 136. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 137. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 138. SWITZERLAND HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 139. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 140. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 141. TURKEY HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 142. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 143. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 144. UNITED ARAB EMIRATES HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 145. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 146. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 147. UNITED KINGDOM HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 148. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 149. HUMAN REPRODUCTIVE TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023
